Supraspinal antinociceptive response to [D-Pen2,5]-enkephalin (DPDPE) is pharmacologically distinct from that to other δ-agonists in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 1135-1141

  Fraser, Graeme L ^a,b,c,e   Pradhan, Amynah A ^b   Clarke, Paul B S ^b   Wahlestedt, Claes ^a,b,d  

^a ASTRAZENECA   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

^c Viron Therapeutics Inc   (Canada)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ANTISENSE OLIGODEOXYNUCLEOTIDE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; DELTORPHIN 2; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE 4 (4 CHLOROPHENYLALANINE)]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; MALE; OLIGONUCLEOTIDES, ANTISENSE; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SOMATOSTATIN; SPINAL CORD;

EID: 0033711309     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used
2. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry
3. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated 'knock-down' of opioid receptors in vivo
4. 6]enkephalin. Covalent attachment via thiol-disuffide exchange
5. Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain
6. Molecular cloning and functional expression of a μ-opioid receptor from rat brain
7. International Union of Pharmacology. XII. Classification of opioid receptors
8. Methods of assessing pain in animals
9. Cloning of a delta opioid receptor by functional expression
10. Action at the mu receptor is sufficient to explain the supraspinal effects of opiates
11. 125I]AR-M100613, a high-affinity radioligand for δ opioid receptors
12. Understanding gene function: Antisense knockdown versus homologous recombination knockout techniques
13. Characterization of mechanical withdrawal responses and effects of μ-, δ- and κ-opioid agonists in normal and μ-opioid receptor knockout mice
14. Oligomerization of mu and delta opioid receptors: Generation of novel functional properties
15. Differential sensitivity of models of antinociception in the rat, mouse and gainea-pig to μ- and κ-opioid receptor agonists
16. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord
17. 35S] GTPγS binding in μ receptor knockout mice
18. 6)enkephalin and naltrindole 5'-isothiocyanate: Evidence for delta receptor subtypes
19. The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
20. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands
21. Novel peptidic mu opioid agonists: Pharmacologic characterization in vitro and in vivo
22. μ Opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
23. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications
24. Activity of the δ-opioid receptor is partially reduced, whereas activity of the κ-receptor is maintained in mice lacking the μ-recepter
25. 2]deltorphin II in mice: Evidence for delta receptor subtypes
26. Contribution of supraspinal μ- and δ-opioid receptors to antinociception in the rat
27. 4] deltorphin in supraspinal antinociception and δ-opioid receptor binding
28. Differential knockdown of δ-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA
29. Behavioural effects of deltorphins in rats
30. Antinociceptive and behavioral effects of synthetic deltorphin analogs
31. Participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase activity in rat olfactory bulb
32. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat
33. Pharmacological mechanisms of opioid analgesics
34. Potency, selectivity, and agonism of opioid ligands at cloned human delta, mu, and kappa receptors
35. The δ-opioid receptor: Molecular pharmacology, signal transduction, and the determination of drug efficacy
36. Antisense mapping DOR-1 in mice: Further support for δ receptor subtypes
37. β-FNA binds irreversibly to the opiate receptor complex: In vivo and in vitro evidence
38. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes
39. 5]enkephalin-induced analgesia
40. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor
41. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat
42. δ-Opioid receptor subtypes and cross-talk with μ-receptors
43. 4]deltorphin with δ-opioid receptor subtypes in vivo
44. Cloning and functional comparison of κ and δ opioid receptors from mouse brain
45. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in δ opioid receptor knockout mice